Researchers found that nebulization of mesenchymal stem cell-derived exosomes did not induce acute allergic or secondary allergic reactions but did promote the absorption of pulmonary lesions and reduce the duration of hospitalization for mild cases of COVID-19 pneumonia.
[Stem Cell Reviews and Reports]